Marinus Pharmaceuticals, Inc. (MRNS)
NASDAQ: MRNS · Real-Time Price · USD
0.230
-0.009 (-3.56%)
At close: Dec 20, 2024, 4:00 PM
0.233
+0.003 (1.39%)
After-hours: Dec 20, 2024, 5:36 PM EST
Marinus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -140.49 | -141.41 | -19.82 | -98.78 | -67.48 | -54.12 | |
| Depreciation & Amortization | 3.7 | 5.36 | 1.37 | 0.36 | 0.33 | 0.28 | |
| Other Amortization | 2.87 | 2.25 | 1.66 | 0.55 | - | - | |
| Loss (Gain) From Sale of Assets | - | - | -107.38 | - | - | 0.04 | |
| Asset Writedown & Restructuring Costs | 0.76 | 0.06 | 0.83 | 0.24 | - | - | |
| Loss (Gain) From Sale of Investments | -0.4 | -1.24 | - | - | 0 | -0.01 | |
| Stock-Based Compensation | 18.87 | 15.56 | 16.06 | 13.87 | 7.64 | 5.67 | |
| Other Operating Activities | -0.28 | -0.75 | 0.47 | -0.41 | 0.63 | 0.09 | |
| Change in Accounts Receivable | 2.12 | 2.61 | 17.89 | -0.45 | - | - | |
| Change in Accounts Payable | -4.45 | 2.11 | 3.75 | 7.84 | 1.88 | 0.89 | |
| Change in Other Net Operating Assets | 2.56 | -2.55 | -27.74 | 21.31 | -3.92 | -1.48 | |
| Operating Cash Flow | -114.75 | -118 | -112.89 | -55.48 | -60.91 | -48.63 | |
| Capital Expenditures | -1.19 | -0.12 | -1.77 | -2.89 | - | -0.39 | |
| Sale of Property, Plant & Equipment | - | 0.01 | 107.55 | - | - | - | |
| Investment in Securities | 36.39 | -28.5 | - | 1.47 | -0.74 | 4.27 | |
| Investing Cash Flow | 35.2 | -28.61 | 105.77 | -1.42 | -0.74 | 3.88 | |
| Long-Term Debt Issued | - | - | 58.51 | 40.26 | - | - | |
| Total Debt Issued | - | - | 58.51 | 40.26 | - | - | |
| Total Debt Repaid | -19.62 | - | - | - | - | - | |
| Net Debt Issued (Repaid) | -19.62 | - | 58.51 | 40.26 | - | - | |
| Issuance of Common Stock | 0.18 | 26.63 | 66.27 | 1.2 | 109.22 | 67.97 | |
| Other Financing Activities | 0.74 | - | -0.04 | -0.15 | - | - | |
| Financing Cash Flow | -18.71 | 26.63 | 124.74 | 41.31 | 109.22 | 67.97 | |
| Net Cash Flow | -98.25 | -119.98 | 117.62 | -15.58 | 47.57 | 23.22 | |
| Free Cash Flow | -115.93 | -118.12 | -114.66 | -58.37 | -60.91 | -49.02 | |
| Free Cash Flow Margin | -368.44% | -381.17% | -450.04% | -380.36% | -3545.52% | - | |
| Free Cash Flow Per Share | -2.04 | -2.20 | -2.93 | -1.59 | -2.23 | -3.60 | |
| Cash Interest Paid | 10.1 | 8.7 | 7.89 | 2.03 | - | - | |
| Cash Income Tax Paid | - | 0.9 | - | - | - | - | |
| Levered Free Cash Flow | -62.81 | -70.09 | -80.74 | -22.99 | -35.68 | -29.01 | |
| Unlevered Free Cash Flow | -54.98 | -61.78 | -75.73 | -21.92 | -35.68 | -29.01 | |
| Change in Net Working Capital | -0.28 | 0.4 | 19.73 | -27.32 | 1.2 | 0.56 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.